Ładuje się......
Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death
BACKGROUND: CRM1 enrichment has been shown to be indicative of invasive as well as chemoresistant tumors. On the other hand, TRAIL, a powerful and specific anti-tumoral agent, has yet to be used effectively to treat gynecological tumors in patients. In the present study, we examined if CRM1, a nucle...
Zapisane w:
| Wydane w: | Cell Commun Signal |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6033231/ https://ncbi.nlm.nih.gov/pubmed/29973205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-018-0252-z |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|